Fundraising Fox

Flow Pharma

Warrensville Heights, US · Delaware corporation

Biotech

Founders & leadership

RMReid Martin Rubsamen
Reid Martin RubsamenCo-founder
RMReid Michael Rubsamen
Reid Michael RubsamenCo-founder
TB
Thomas BradyExecutive
LJ
Lester John LloydExecutive

Board

PS
Pamela SteeleBoard director
AT
Anthony TufaroBoard director
TB
Tikoes BlankenbergBoard director
BO
Babatunde OtulanaBoard director

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 4 rounds · 2011–2024

▶$225KraisedAug 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pamela SteeleDirector
  • Anthony TufaroDirector
  • Reid Martin RubsamenExecutive Officer, Director
  • Tikoes BlankenbergDirector
  • Babatunde OtulanaDirector
Offering amount
$40M
Amount sold
$225K
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$180KraisedNov 2022 · 8 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Gil Van BokkelenExecutive Officer
  • Reid Martin RubsamenExecutive Officer, Director
  • Tikoes BlankenbergDirector
  • Thomas BarnishExecutive Officer
  • Stephen FarrDirector
  • Charles Vincent HerstExecutive Officer
  • Tom BradyExecutive Officer
  • Pamela SteeleDirector
  • Babatunde OtulanaDirector
Offering amount
$10.5M
Amount sold
$180K
Finders' fees
$500K
Placement agents
Carleton McKenna Advisors, LLC
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$2.3MraisedFeb 2018 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Reid Michael RubsamenExecutive Officer, Director
  • Thomas BradyExecutive Officer
  • Lester John LloydExecutive Officer, Director
Amount sold
$2.3M
Minimum investment
$5K
Proceeds to insiders
$300K
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedFeb 2018 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Reid M RubsamenExecutive Officer, Director
  • Lester J LloydExecutive Officer, Director
Amount sold
$1.1M
Minimum investment
$12.5K
First sale
Apr 2011
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Radiuspharm8 shared keywordsRadius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).

Companies competing with Flow Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of DefenseOffice for Chemical and Biological DefensePhase IISTTR2020$537.5K
Department of DefenseOffice for Chemical and Biological DefensePhase ISTTR2018$136.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Biotech Flow Pharma, Inc. Announces Formation of China Joint Venture With Investing Partner Button Capitalfinance.yahoo.com · Sep 2018

Frequently asked questions

Who founded Flow Pharma?
Flow Pharma was founded by Reid Martin Rubsamen, Reid Michael Rubsamen.
How much funding has Flow Pharma raised?
Flow Pharma has disclosed $3.8M raised across 4 rounds.
Where is Flow Pharma headquartered?
Flow Pharma is headquartered in Warrensville Heights, US.